These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2357958)

  • 21. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy.
    Sander JW; Trevisol-Bittencourt PC; Hart YM; Patsalos PN; Shorvon SD
    Epilepsy Res; 1990 Dec; 7(3):226-9. PubMed ID: 2289481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R; Privitera MD; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin as add-on treatment for epilepsy.
    Brigo F; Del Felice A
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006967. PubMed ID: 22696363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The anticonvulsive activity of the 1,4-dihydropyridine derivative riodipine and other anticonvulsants when used in combination].
    Kryzhanovskiĭ GN; Karpova MN; Abrosimov IIu
    Biull Eksp Biol Med; 1993 Jul; 116(7):15-7. PubMed ID: 8400164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical approach to the management of intractable epilepsy.
    Aicardi J
    Dev Med Child Neurol; 1988 Aug; 30(4):429-40. PubMed ID: 3049187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].
    Barcs Gábor ; Szűcs A; Horváth A; Kamondi A
    Ideggyogy Sz; 2015 Jan; 68(1-2):23-9. PubMed ID: 25842913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clobazam for intractable pediatric epilepsy.
    Sheth RD; Ronen GM; Goulden KJ; Penney S; Bodensteiner JB
    J Child Neurol; 1995 May; 10(3):205-8. PubMed ID: 7642889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with adjunctive perampanel in adult patients with uncontrolled epilepsy: A UK and Ireland multicentre study.
    Shah E; Reuber M; Goulding P; Flynn C; Delanty N; Kemp S
    Seizure; 2016 Jan; 34():1-5. PubMed ID: 26615577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allopurinol as an add-on drug in the management of intractable epilepsy.
    Sander JW; Patsalos PN
    Epilepsy Res; 1988; 2(3):223-5. PubMed ID: 3197692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory epilepsy: treatment with new antiepileptic drugs.
    Datta PK; Crawford PM
    Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM.
    Hamer H; Baulac M; McMurray R; Kockelmann E
    Seizure; 2016 Jan; 34():66-73. PubMed ID: 26735004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination therapy for epilepsy].
    Fröscher W; Rösche J
    Fortschr Neurol Psychiatr; 2013 Jan; 81(1):9-20. PubMed ID: 22450761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Levetiracetam in the treatment of epilepsy].
    Mariero Klees T; Brodtkorb E; Nakken KO; Lossius R; Johannessen SI
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1539-41. PubMed ID: 12822020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients' preferences for treatment outcomes of add-on antiepileptic drugs: a conjoint analysis.
    Manjunath R; Yang JC; Ettinger AB
    Epilepsy Behav; 2012 Aug; 24(4):474-9. PubMed ID: 22770879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood.
    Gulati P; Cannell P; Ghia T; Bint L; Walsh P; Ghosh S; Nagarajan L
    J Paediatr Child Health; 2015 Aug; 51(8):794-7. PubMed ID: 25683595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review.
    Paquette V; Culley C; Greanya ED; Ensom MH
    Seizure; 2015 Feb; 25():1-17. PubMed ID: 25645629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.